Cyclerion Therapeutics Inc (CYCN)
3.50
+0.28
(+8.76%)
USD |
NASDAQ |
Apr 19, 13:14
Cyclerion Therapeutics Price: 3.50 for April 19, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 3.218 | 3.218 | 3.218 | 3.218 | 0.000 |
| Apr 17, 2024 | 3.454 | 3.454 | 3.218 | 3.218 | 443.00 |
| Apr 16, 2024 | 3.28 | 3.451 | 3.18 | 3.18 | 527.00 |
| Apr 15, 2024 | 3.50 | 3.50 | 3.32 | 3.32 | 2358.00 |
| Apr 12, 2024 | 3.00 | 3.548 | 3.00 | 3.37 | 14231.00 |
| Apr 11, 2024 | 2.955 | 3.107 | 2.80 | 3.050 | 4140.00 |
| Apr 10, 2024 | 3.00 | 3.10 | 2.80 | 3.10 | 2311.00 |
| Apr 09, 2024 | 3.10 | 3.30 | 3.01 | 3.01 | 22283.00 |
| Apr 08, 2024 | 3.20 | 3.20 | 2.91 | 3.20 | 1399.00 |
| Apr 05, 2024 | 3.30 | 3.30 | 3.30 | 3.30 | 507.00 |
| Apr 04, 2024 | 3.47 | 3.98 | 3.39 | 3.39 | 2904.00 |
| Apr 03, 2024 | 3.16 | 3.16 | 3.16 | 3.16 | 0.000 |
| Apr 02, 2024 | 3.065 | 3.16 | 3.06 | 3.16 | 1749.00 |
| Apr 01, 2024 | 3.32 | 3.32 | 3.07 | 3.07 | 1432.00 |
| Mar 28, 2024 | 3.20 | 3.45 | 3.20 | 3.20 | 18646.00 |
| Mar 27, 2024 | 3.05 | 3.083 | 2.92 | 3.080 | 993.00 |
| Mar 26, 2024 | 3.08 | 3.08 | 3.08 | 3.08 | 636.00 |
| Mar 25, 2024 | 3.03 | 3.03 | 3.03 | 3.03 | 312.00 |
| Mar 22, 2024 | 3.27 | 3.27 | 3.05 | 3.05 | 474.00 |
| Mar 21, 2024 | 3.03 | 3.25 | 3.03 | 3.20 | 1564.00 |
| Mar 20, 2024 | 2.92 | 3.30 | 2.92 | 3.30 | 1312.00 |
| Mar 19, 2024 | 3.22 | 3.22 | 3.10 | 3.10 | 509.00 |
| Mar 18, 2024 | 2.88 | 3.20 | 2.88 | 3.20 | 4070.00 |
| Mar 15, 2024 | 3.36 | 3.36 | 3.10 | 3.25 | 972.00 |
| Mar 14, 2024 | 3.10 | 3.38 | 3.10 | 3.36 | 1409.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.91
Minimum
Nov 27 2023
332.80
Maximum
May 10 2019
60.37
Average
43.60
Median
Apr 30 2021
Price Benchmarks
| Eli Lilly and Co | 730.68 |
| iBio Inc | 1.74 |
| AbbVie Inc | 166.22 |
| Agile Therapeutics Inc | 0.368 |
| NovaBay Pharmaceuticals Inc | 0.0821 |
Price Related Metrics
| PS Ratio | 15.26 |
| Price to Book Value | 0.8403 |
| Earnings Yield | -86.00% |
| Market Cap | 9.485M |